ArticleEuropean radiology2026
A comprehensive multi-task deep learning model for kidney cancer: histological subtyping, clinical staging, and anatomical complexity grading.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Central Role of Imaging in Renal Cell Carcinoma: A Comprehensive Review of Tumor Aggressiveness, Histology, and Radiomics.Cancers · 2026Review
- Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo develop and validate a multi-task deep learning (MTDL) model using multiphase contrast-enhanced CT (CECT) for simultaneously assessing histological subtypes, clinical stages, and anatomical complexity grades of solid malignant renal tumors. MATERIALS AND
methodsThis two-center retrospective study included patients with solid malignant renal tumors and their preoperative kidney CECT images. A progressive layered extraction (PLE)-based MTDL model was trained and externally tested. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA), compared with the results of five radiologists.
resultsAmong 798 patients (mean age, 54 ± 12 years; 279 females; Center A: n = 620, Center B: n = 178), 597 (74.8%) had clear cell renal cell carcinomas (ccRCC), 150 (18.8%) were clinical staging III/IV, and 187 (23.4%) had high anatomical complexity. On the external test set, the MTDL model achieved AUCs of 0.89 (95% CI: 0.82, 0.94) for distinguishing ccRCC from non-ccRCC, 0.87 (95% CI: 0.81, 0.93) for clinical staging (I/II vs. III/IV), and 0.87 (95% CI: 0.82, 0.92) for anatomical complexity grading (low-intermediate vs. high). The MTDL model outperformed single-task deep learning (STDL) in clinical staging (AUC: 0.87 vs. 0.82, p = 0.022), showed higher net benefit on DCA, and demonstrated better diagnostic performance than junior radiologists in histological subtyping and clinical staging. Additionally, it used 68% less memory and was 60% faster than STDL models.
conclusionThe CECT-based MTDL model demonstrated robust performance in simultaneously predicting histological subtypes, clinical stages, and anatomical complexity grades of malignant renal tumors. KEY POINTS: Question Accurate preoperative description of the histological subtyping, clinical staging, and anatomical complexity of malignant renal tumors is crucial for treatment decision-making. Findings By sharing features, the multi-task deep learning algorithm model enhances clinical staging performance and significantly improves computational efficiency in predicting all three tasks simultaneously. Clinical relevance The multi-task deep learning algorithm model enables rapid and accurate comprehensive preoperative evaluation of renal tumors, which assists surgeons in optimizing surgical plans and promotes the advancement of renal tumor management toward precision and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.